Publications by authors named "Y Merabet"
Objective: To investigate if the type of unilateral amblyopia can impact the improvement of visual acuity in amblyopic eyes during a longitudinal interventional study involving standard occlusion therapy in children.
Methods: A longitudinal and interventional study of 91 children, aged 3-9 years (6.12 ± 1.
Article Synopsis
- Advancements in computing power and storage have led to improved data analysis in air quality, enhancing public health protection, although accurate pollutant predictions are still needed.
- This study proposes a new hybrid deep learning model, EFS-GA-LSTM, for predicting multistep hourly PM concentrations using historical data and optimized through modified genetic algorithms and feature selection techniques.
- The EFS-GA-LSTM model outperforms other optimization methods in forecasting tasks, showing better accuracy metrics like root mean square error and correlation coefficient for 3-hour predictions.
Promising PD-1 antagonists for liver cancer: an evaluation of phase II and III results.
Expert Opin Emerg Drugs
December 2024
Introduction: Hepatocellular carcinoma (HCC), the most common primary liver cancer, is a major cause of cancer-related morbidity and mortality. Limited treatment options for advanced stages highlight the need for effective therapies.
Areas Covered: This review explores immune checkpoint inhibitors (ICIs), specifically PD-1, PD-L1, and CTLA-4 inhibitors, as emerging treatments for advanced HCC.
Background And Objective: Ensuring a high level of adherence to wearing spectacles is essential to preserve eye health and achieve optimal vision correction. Comprehending the factors influencing adherence to wearing spectacles can inform strategies to improve eye care outcomes. This study aimed to assess the prevalence and factors influencing adherence to wearing spectacles among Moroccan adults residing the Beni-Mellal Khenifra region.
View Article and Find Full Text PDFPurpose: This manuscript reports on the occurrence of early and frequent erythrocytosis in advanced hepatocellular carcinoma (HCC) patients treated with lenvatinib.
Methods: A cohort of 23 patients with advanced HCC, treated with this antiangiogenic drug for at least one month, was retrospectively analyzed.
Results: These patients (82.